Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Upadacitinib may cause hair loss.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

3-Deoxysappanchalcone helps human hair cells grow and stimulates hair growth in mice by affecting certain cell signaling pathways.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

New alopecia treatments aim for better results and fewer side effects.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

New treatments offer hope for better managing hidradenitis suppurativa.

MSC-EVs and UCB-EVs improve skin wound healing and reduce scarring.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Low dose methotrexate does not increase hair fall and may reduce it.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.